BeiGene is developing a pipeline of oral small molecules and monoclonal antibodies to fight cancer. Get up to date with the BeiGene hematology pipeline and clinical trials.

Factsheet outlining a new therapeutic approach for patients with B-cell malignancies who have become intolerant to certain BTKi therapies.

Factsheet describing the treatment of Waldenström's macroglobulinemia (WM) by inhibiting BTK.